Transcriptional Dosage of Oncogenic KRAS Drives Lung Adenocarcinoma Cell States, Progression and Metastasis
Michela Serresi, Ali Osman Çetin, Yuliia Dramaretska, Sonia Kertalli, Matthias Jürgen Schmitt, Heike Naumann, Maria Zschummel, Marie-Liesse Asselin-Labat, Lucas F. Maciel, Jeroen Declercq, Jean‐Christophe Marine, Gaetano Gargiulo
This study shows that varying levels of oncogenic KRAS drive different cell states and metastatic progression in lung adenocarcinoma, with implications for treatment.
bioRxiv · Dec 29, 2024 · PreprintCancer Biology